Symbiotec Pharmalab IPO Opens for Subscription on August 24
· Business · LiveMint, Economic Times
Symbiotec Pharmalab will launch its initial public offering on August 24, seeking to raise ₹1,757 crore. The company has set a price band of ₹938–₹988 per equity share for the issue, which remains open for bidding until August 27. Retail investors can participate with a minimum investment of ₹14,820 for a lot size of 15 shares. The offering includes a fresh issue of ₹150 crore and an offer for sale of ₹1,607 crore by existing shareholders. Shares are expected to list on the NSE and BSE on September 1.
Why it matters
This IPO provides retail investors an opportunity to invest in the pharmaceutical sector, with proceeds from the fresh issue earmarked for debt repayment.
Read the original report — LiveMint
Join us on Telegram
Breaking news the moment it lands. At 10,000 members we ship the Android app.